跳至主要内容
临床试验/NCT02908022
NCT02908022已完成不适用

Optimization of Brain-based Mechanisms Supporting Psychosocial Aspects of Acupuncture Therapy - a Hyperscanning fMRI Study

Massachusetts General Hospital2 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2016年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
180
试验地点
2
主要终点
Magnitude of patient/clinician concordance in brain activation of mirror brain circuitry during electroacupuncture therapy

研究概览

简要总结

The overall aim of the present proposal is to investigate how patients' and clinicians' (Licensed acupuncturists, LAc) neural and autonomic processes during treatment interaction correlate to patient outcomes. Male and female healthy clinicians and fibromyalgia patients will be recruited for the study.

详细描述

First phase: At the training sessions, both clinician and patient will fill out a set of questionnaires and go through standardized psychophysical tests for assessing visual displays of affect. They will also be informed of the efficacy of the electroacupuncture in relieving pain during the experiment. During the clinical examination, the clinician will follow clinical exam protocol and do an intake of the fibromyalgia (FM) patient, including a physical exam and pain assessment. While in the scanner, the clinician will receive painful stimulations with a pressure cuff on the leg over an 8-minute paradigm in order to get cerebral representation. The patient will then be placed in a different scanner running simultaneously and will experience painful stimulations with a pressure cuff while interacting via live camera with the clinician in the other scanner. When visually prompted via cues on a screen, the clinician will activate analgesia for the patient, through a response device (response box) in clinician's one hand. After each trial of pain with/without treatment, the clinicians will be asked "how did you feel about the outcome (extremely positive - extremely negative)", and how satisfied are you (Not at all satisfied - Very satisfied) on Numerical Rating Scales (NRS). The patient will also give ratings after each trial of pain with/without treatment. They will be asked "how did you feel about the outcome (extremely positive - extremely negative)?", and "how painful was the cuff (Not painful - Extremely painful)?" on NRS. After the scan, both clinician and patient will be asked to rate anxiety during the presence of visual stimulus preceding cuff activation (not at all anxious - extremely anxious). After the final MRI session, the clinician and the patient will both be given the chance to report their responses to the treatment and then debriefed.

Second phase: At training session both clinician and patient will fill out a set of questionnaires. During the first MRI session the clinician will receive painful stimulations with a pressure cuff on the leg over a 6-minute paradigm in order to get cerebral representation. The patient will then be placed in a different scanner running simultaneously and will experience pain stimulation with the pressure cuff while interacting via live camera with the clinician in the other scanner. When visually prompted via cues on a screen, the clinician will activate analgesia for the patient, through a response device (response box) in clinician's hand. Both patient and acupuncturist will be asked to give ratings of pain and other parameters during the scan. Following the first MRI session, the patient will attend biweekly acupuncture treatment sessions with the clinician (6 treatments total). During the first session the clinician will be introduced to the patient and do a general intake in addition to the acupuncture treatment. The final MRI session will be identical to the first.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
21 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Inclusion Criteria (Healthy Clinicians):
  • •Male and Female healthy clinicians
  • •25-60 years of age
  • •Ability to read and understand English; English can be a second language provided that the participant feels that he/she understand all the questions used in the assessment measures.
  • •Inclusion Criteria (Fibromyalgia Patients):
  • •Have a clinical diagnosis of fibromyalgia and meet the Wolfe et al 2011 research criteria for fibromyalgia for at least one year
  • •Are on stable doses of medication for 30 days prior to entering the study and agree not to change medications or dosages during the trial
  • •21 to 60 years of age
  • •Right-handed
  • •Ability to read and understand English; English can be a second language provided that the participant feels that he/she understand all the questions used in the assessment measures

排除标准

  • •(All participants):
  • •Any longer period of work experience involving pain treatment, pain rehabilitation etc. This is in order to exclude participants with biased expectations regarding different methods of analgesia
  • •Presence of any illness or medication use that is judged to interfere with the trial. For example: psychiatric disorder according to the DSM-IV manual, medication that can influence cognition or emotional processing, i.e. sleep medication, antidepressants, anti-convulsants or opioids
  • •Presence of any contraindications to fMRI scanning. For example: cardiac pacemaker, metal implants, fear of closed spaces, pregnancy
  • •Inability to respond accurately to the pain-relieving intervention in the behavioral part of the experiment, indicating a lack of response to the expectancy manipulation. If the healthy volunteer or clinician is not a responder to the behavioral expectancy induction he or she will be excluded
  • •Unwillingness to receive brief experimental pain
  • •Leg pain or health issues that may interfere with the study procedures
  • •Exclusion Criteria (Specific to Fibromyalgia Patients):
  • •Comorbid acute pain condition
  • •Comorbid chronic pain condition that is rated by the subject as more painful than fibromyalgia
  • •Current use of opioid analgesics or stimulant medications or the fatigue associated with sleep apnea or shift work (e.g., modafinil)
  • •Documented peripheral neuropathy
  • •Any psychiatric disorder involving a history of psychosis (e. g schizophrenia, bipolar disorder, severe personality disorders)
  • •History of anxiety disorders or significant anxiety symptoms interfering with fMRI procedures (e.g., panic)
  • •Psychiatric hospitalization in the past 6 months
  • •Any impairment, activity or situation that in the judgment of the Study Coordinator or Principal Investigator would prevent satisfactory completion of the study protocol.
  • •Is an actual clinical patient of the clinician subject
  • •Inclusion Criteria (healthy individuals):
  • •Male and female healthy clinicians.
  • •25-65 years of age (clinicians)
  • •Ability to read and understand English; English can be a second language provided that the participant feels that he/she understand all the questions used in the assessment measures.
  • •Inclusion Criteria (FM patients):
  • •Have a clinical diagnosis of fibromyalgia and meet the Wolfe et al 2011 research criteria for fibromyalgia for at least one year
  • •Are on stable doses of medication for 30 days prior to entering the study and agree not to change medications or dosages during the trial
  • •21-65 years of age
  • •Ability to read and understand English; English can be a second language provided that the participant feels that he/she understand all the questions used in the assessment measures.
  • •Exclusion Criteria (all participants):
  • •Any longer period of work experience involving pain treatment, pain rehabilitation etc. This is in order to exclude participants with biased expectations regarding different methods of analgesia.
  • •Presence of any illness that is judged to interfere with the trial. For example: psychiatric disorder according to the DSM-IV manual
  • •Presence of any contraindications to fMRI scanning. For example: cardiac pacemaker, metal implants, fear of closed spaces, pregnancy.
  • •Inability to respond accurately to the pain-relieving intervention in the behavioral part of the experiment, indicating a lack of response to the expectancy manipulation. If the healthy volunteer or clinician is not a responder to the behavioral expectancy in-duction he or she will be excluded.
  • •Unwillingness to receive brief experimental pain.
  • •Leg pain or health issues that may interfere with the study procedures.
  • •Exclusion Criteria (specific to FM patients):
  • •Comorbid acute pain condition
  • •Comorbid chronic pain condition that is rated by the subject as more painful than fibromyalgia
  • •Documented peripheral neuropathy
  • •Any psychiatric disorder involving a history of psychosis (e. g schizophrenia, bipolar disorder, severe personality disorders)
  • •History of anxiety disorders or significant anxiety symptoms interfering with fMRI procedures (e.g., panic)
  • •Psychiatric hospitalization in the past 6 months
  • •Marijuana use greater than once daily and unwillingness to withhold from consumption 12 hours prior to scans or lab visits
  • •Unwillingness to withhold from consuming nicotine 4 hours prior to scans
  • •Any impairment, activity or situation that in the judgment of the Study Coordinator or Principal Investigator would prevent satisfactory completion of the study protocol.
  • •Is an actual clinical patient of the clinician subject

研究组 & 干预措施

Interaction

Experimental

Phase 1:

Prior to the MRI sessions, the clinician will be introduced to the patient and do a general intake of physical examination.

During the MRI sessions, the patient will receive experimental pressure pain via the Hokanson Rapid Cuff Inflator and electroacupuncture analgesia to the leg for pain relief.

干预措施: Hokanson Rapid Cuff Inflator (Device)

Longitudinal

Experimental

Phase 2:

Prior to first MRI session, both clinician and patient will go through a training visit.

During the first MRI session, the patient will receive experimental pressure pain to the left leg via Hokanson Rapid Cuff Inflator and electroacupuncture to the same leg for pain relief.

Following the first MRI session, the patient will attend biweekly acupuncture treatment sessions with the clinician (6 treatments total). During the first session the clinician will be introduced to the patient and do a general intake in addition to the acupuncture treatment.

The final MRI session will be identical to the first. The patient will receive experimental pressure pain via Hokanson Rapid Cuff Inflator and electroacupuncture to the same leg for pain relief.

干预措施: Electroacupuncture Analgesia (Device)

Longitudinal

Experimental

Phase 2:

Prior to first MRI session, both clinician and patient will go through a training visit.

During the first MRI session, the patient will receive experimental pressure pain to the left leg via Hokanson Rapid Cuff Inflator and electroacupuncture to the same leg for pain relief.

Following the first MRI session, the patient will attend biweekly acupuncture treatment sessions with the clinician (6 treatments total). During the first session the clinician will be introduced to the patient and do a general intake in addition to the acupuncture treatment.

The final MRI session will be identical to the first. The patient will receive experimental pressure pain via Hokanson Rapid Cuff Inflator and electroacupuncture to the same leg for pain relief.

干预措施: Hokanson Rapid Cuff Inflator (Device)

Interaction

Experimental

Phase 1:

Prior to the MRI sessions, the clinician will be introduced to the patient and do a general intake of physical examination.

During the MRI sessions, the patient will receive experimental pressure pain via the Hokanson Rapid Cuff Inflator and electroacupuncture analgesia to the leg for pain relief.

干预措施: Electroacupuncture Analgesia (Device)

No Interaction

Experimental

Phase 1:

The clinician and the patient will first be introduced at the MRI sessions.

During the MRI sessions, the patient will receive experimental pressure pain via the Hokanson Rapid Cuff Inflator and electroacupuncture analgesia to the leg for pain relief.

干预措施: Electroacupuncture Analgesia (Device)

No Interaction

Experimental

Phase 1:

The clinician and the patient will first be introduced at the MRI sessions.

During the MRI sessions, the patient will receive experimental pressure pain via the Hokanson Rapid Cuff Inflator and electroacupuncture analgesia to the leg for pain relief.

干预措施: Hokanson Rapid Cuff Inflator (Device)

结局指标

主要结局

Magnitude of patient/clinician concordance in brain activation of mirror brain circuitry during electroacupuncture therapy

时间窗: Up to 60 months

Patient/clinician concordance in brain activation will be assessed by functional Magnetic Resonance Imaging, simultaneously for both the patient and the clinician

次要结局

  • Correlation between patient/clinician brain activity concordance and pain relief from electroacupuncture therapy(Up to 60 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Vitaly Napadow, Ph.D., Lic.Ac.

Associate Professor, Harvard Medical School; Director, Center for Integrative Pain NeuroImaging (CiPNI)

Massachusetts General Hospital

研究点 (2)

Loading locations...

相似试验